3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Colorectal Neoplasms
51
Rectal Neoplasms
27
Colonic Neoplasms
16
Stomach Neoplasms
14
Carcinoma, Hepatocellular
14
Neoplasm Metastasis
9
Adenocarcinoma Of Esophagus
7
Esophageal Neoplasms
6
Neoplasms
5
Cholangiocarcinoma
5
Recurrence
3
Pancreatic Neoplasms
3
Esophageal Squamous Cell Carcinoma
3
Digestive System Neoplasms
3
Adenocarcinoma
3
Ovarian Neoplasms
2
Liver Neoplasms
2
Intestinal Neoplasms
2
Gastrointestinal Neoplasms
2
Gastrointestinal Diseases
2
Cirrhosis, Familial, with Pulmonary Hypertension
2
Biliary Tract Neoplasms
2
Peritoneal Neoplasms
1
Pancreatic Adenocarcinoma
1
Operable T2-3N+M0 Rectal Cancer (Stage III)
1
Neurotoxicity Syndromes
1
Metastatic Colorectal Adenocarcinoma
1
Locally Advanced Pancreatic Carcinoma(LAPC)
1
Locally Advanced Colorectal Carcinoma
1
Intestinal Diseases
1
Interventions
alvimopan
2
Oxaliplatin
2
Capecitabine
2
pembrolizumab
1
alectinib
1
Ocoxin
1
Folfox protocol
1
Cyclophosphamide
1
Chemoradiotherapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Intestinal Diseases
×
Folfox protocol
×
Clear all
NCT03280407
2017-09-28
NEOLAR
Zealand University Hospital
Phase 2
Unknown
124 enrolled